nngu007
JF-Expert Member
- Aug 2, 2010
- 15,862
- 5,797
NEWS
By ROSEMARY MIRONDO
Posted Saturday, October 13 2012 at 18:42
IN SUMMARY
The discovery of counterfeit anti-retrovirals could scuttle Tanzania Pharmaceutical Industries Ltd's - the country's sole manufacturer of ARVs - export plans.
The government has banned the Arusha-based company from further producing and distributing ARVs as it investigates the matter.
This comes in the backdrop of plans by TPI to set up a modern plant to manufacture ARVs, deputy managing director Zarina Madabida said.
"We are conducting our own investigations to determine the motive to discredit TPI as we are about to inaugurate a Tsh10 billion ($6.4 million) plant under a grant from the European Union, with an eye on the international market," Ms Madabida said.
She added that the decision to halt production was a big blow to the company as it was likely to affect business especially at the new plant, which is designed to produce ARVs and other drugs for opportunistic diseases.
"The government has served us a 14-day notice to explain the fake drugs but it is inconceivable that we can fake our own," said Ms Madabida.
Additionally, the Minister of Health and Social Welfare, Hussein Mwinyi suspended three top officials at Medical Stores Department, a government entity and sole distributor of ARVs in the country.
The minister said so far 9,570 tins of the fake drug had been recalled and about 2,600 are still being stored in medical stores.
TPI got the technology transfer to manufacture ARVs from Thailand and has been doing so since 2007
By ROSEMARY MIRONDO
Posted Saturday, October 13 2012 at 18:42
IN SUMMARY
- The government has banned the Arusha-based company from further producing and distributing ARVs as it investigates the matter.
- 9,570 tins of the fake drug had been recalled and about 2,600 are still being stored in medical stores.
The discovery of counterfeit anti-retrovirals could scuttle Tanzania Pharmaceutical Industries Ltd's - the country's sole manufacturer of ARVs - export plans.
The government has banned the Arusha-based company from further producing and distributing ARVs as it investigates the matter.
This comes in the backdrop of plans by TPI to set up a modern plant to manufacture ARVs, deputy managing director Zarina Madabida said.
"We are conducting our own investigations to determine the motive to discredit TPI as we are about to inaugurate a Tsh10 billion ($6.4 million) plant under a grant from the European Union, with an eye on the international market," Ms Madabida said.
She added that the decision to halt production was a big blow to the company as it was likely to affect business especially at the new plant, which is designed to produce ARVs and other drugs for opportunistic diseases.
"The government has served us a 14-day notice to explain the fake drugs but it is inconceivable that we can fake our own," said Ms Madabida.
Additionally, the Minister of Health and Social Welfare, Hussein Mwinyi suspended three top officials at Medical Stores Department, a government entity and sole distributor of ARVs in the country.
The minister said so far 9,570 tins of the fake drug had been recalled and about 2,600 are still being stored in medical stores.
TPI got the technology transfer to manufacture ARVs from Thailand and has been doing so since 2007